Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03818061
Title Atezolizumab and Bevacizumab in Patients With Recurrent or Metastatic Squamous-cell Carcinoma of the Head and Neck (ATHENA)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Centre Leon Berard

oropharynx cancer

laryngeal squamous cell carcinoma

hypopharynx cancer

oral squamous cell carcinoma


Atezolizumab + Bevacizumab

Age Groups: senior | adult
Covered Countries FRA

No variant requirements are available.